Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Pharmaceutical Group Co., Ltd. (SPG) is a prominent Chinese pharmaceutical manufacturer specializing in the production of anti-infective medications. Established in 1958 and headquartered in Chengdu, it is recognized as one of the largest and oldest production bases for antibiotics in Southwest China, particularly for penicillins and cephalosporins. The company's extensive portfolio includes a wide range of generic products such as amoxicillin, ceftriaxone, and cefotaxime, available in various formulations including powder injections, tablets, and capsules. Currently operating as a subsidiary of the Sichuan Industrial Investment Group, SPG remains a key supplier of essential medicines within China's healthcare system, maintaining multiple GMP-certified production lines and a robust domestic distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Pharmaceutical.